- Home
- MASK vs CRIS Comparison
MASK vs CRIS Comparison
Compare MASK & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MASK
- CRIS
- Stock Information
- Founded
- MASK 2017
- CRIS 2000
- Country
- MASK China
- CRIS United States
- Employees
- MASK N/A
- CRIS N/A
- Industry
- MASK
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MASK
- CRIS Health Care
- Exchange
- MASK NYSE
- CRIS Nasdaq
- Market Cap
- MASK 31.7M
- CRIS 32.8M
- IPO Year
- MASK 2025
- CRIS 2000
- Fundamental
- Price
- MASK $2.90
- CRIS $2.84
- Analyst Decision
- MASK
- CRIS Strong Buy
- Analyst Count
- MASK 0
- CRIS 3
- Target Price
- MASK N/A
- CRIS $23.00
- AVG Volume (30 Days)
- MASK 25.1K
- CRIS 28.2K
- Earning Date
- MASK 01-01-0001
- CRIS 05-06-2025
- Dividend Yield
- MASK N/A
- CRIS N/A
- EPS Growth
- MASK 55.43
- CRIS N/A
- EPS
- MASK 0.15
- CRIS N/A
- Revenue
- MASK $4,561,963.00
- CRIS $10,259,000.00
- Revenue This Year
- MASK N/A
- CRIS N/A
- Revenue Next Year
- MASK N/A
- CRIS N/A
- P/E Ratio
- MASK $18.21
- CRIS N/A
- Revenue Growth
- MASK 172.95
- CRIS 0.44
- 52 Week Low
- MASK $2.50
- CRIS $2.57
- 52 Week High
- MASK $3.99
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- MASK N/A
- CRIS 41.65
- Support Level
- MASK N/A
- CRIS $2.57
- Resistance Level
- MASK N/A
- CRIS $3.15
- Average True Range (ATR)
- MASK 0.00
- CRIS 0.17
- MACD
- MASK 0.00
- CRIS -0.02
- Stochastic Oscillator
- MASK 0.00
- CRIS 44.26
About MASK 3 E NETWORK TECHNOLOGY GROUP LTD
3 E Network Technology Group Ltd is a business-to-business ("B2B") information technology ("IT") business solutions provider. It focuses on integrated software and hardware solutions in the property management and exhibition services spaces and expanded software solutions offering to a variety of industries and sectors, including food establishments, real estate, exhibition & conferencing, and clean energy utilities. The business includes two main portfolios, namely the software development portfolio and exhibition and conference portfolio. Maximum revenue is generated from the software development portfolio.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.